[FIRST GENERATION PROTEASE INHIBITOR BASED TRIPLE THERAPY FOR HCV GENOTYPE 1--LOOKING BACK WHILE PROCEEDING TO A PROMISING ERA]. [electronic resource]
Producer: 20160831Description: 272-5, 324, 323 p. digitalISSN:- 0017-7768
- Adult
- Antiviral Agents -- administration & dosage
- DNA, Viral
- Drug Carriers
- Drug Therapy, Combination
- Female
- Hepacivirus -- drug effects
- Hepatitis C -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Israel
- Male
- Oligopeptides -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Proline -- administration & dosage
- Protease Inhibitors -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Retrospective Studies
- Ribavirin -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.